1
0
0
News
Netzwerk-Profile
LinkedIn: Ayse Erbakan | LinkedIn
Ayse Erbakan adlı kullanıcının LinkedIn'deki profesyonel profilini görüntüleyin. LinkedIn, Ayse Erbakan gibi profesyonellere, tavsiye edilen iş adayları, sektör ...
Dokumente zum Namen
PUBLICATIONS JOURNAL (FULL PAPERS)uitm.edu.my
medicine.uitm.edu.my
R.Dagenais, Antonio L. Dans, Rafael Diaz, Ayse N. Erbakan, Noorhassim Ismail, Iqbal. Romaina, Roya Kelishadi, Rasha Khatib, Fernando Lanas, Scott A.Lear, ...
Wissenschaftliche Veröffentlichungen
Articles Inequalities in the use of secondary prevention of ...ScienceDirect
www.sciencedirect.com
von A Murphy · · Zitiert von: 97 — Ayse N Erbakan MD n , Noorhassim Ismail MD o , Romaina Iqbal PhD p , Roya Kelishadi MD q , Rasha Khatib PhD r , Fernando Lanas PhD s
Sonstiges
evidence from the PURE observational study Adrianna.SlidePlayer
slideplayer.com
... MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, Roya Kelishadi, MD, Rasha Khatib, PhD, Fernando Lanas, PhD, Prof Scott A Lear, PhD, ...
Inequalities in the use of secondary prevention ...The Aga Khan University
scholars.aku.edu
... Jephat Chifamba, Clara K. Chow, Daniel J. Corsi, Gilles R. Dagenais, Antonio L. Dans, Rafael Diaz, Ayse N. Erbakan, Noorhassim Ismail, Romaina Iqbal, ...
AbstractmedRxiv
www.medrxiv.org
— Dans , Rafael Diaz , Ayse N. Erbakan , Noorhassim Ismail , Romaina Iqbal , Roya Kelishadi , Rasha Khatib , Fernando Lanas , Lear Scott A , Wei ...
(PDF) Inequalities in the use of secondary prevention of ...Academia.edu
www.academia.edu
... Ayse N Erbakan, Noorhassim Ismail, Romaina Iqbal, Roya Kelishadi, Rasha Khatib, Fernando Lanas, Scott A Lear, Wei Li, Jia Liu, Patricio Lopez-Jaramillo, ...
C-peptide Concentrations in Type 2 Diabetes Treated WithClincosm
www.clincosm.com
Principal Investigator: Ayşe N Erbakan, MD, IMU Doctoral program; Study Director: Mehmet Uzunlulu, Prof, IMU Goztepe Education and Research Hospital ... None provided. Responsible Party: Ayse N Erbakan, Principal Investigator, Goztepe Training and Research Hospital. ClinicalTrials.gov Identifier: NCT
Die Wirkung von SGLT2-Inhibitoren auf die ICH GCPichgcp.net
ichgcp.net
... und BDNF-Spiegel bei Patienten mit Typ-2-Diabetes. 7. Dezember aktualisiert von: Ayse N Erbakan, Goztepe Training and Research Hospital ...
Inequalities in the use of secondary prevention ...National Institutes of Health (.gov)
pubmed.ncbi.nlm.nih.gov
von A Murphy · · Zitiert von: 97 — ... Gilles R Dagenais , Antonio L Dans , Rafael Diaz , Ayse N Erbakan , Noorhassim Ismail , Romaina Iqbal , Roya Kelishadi , Rasha Khatib , Fernando Lanas ...
Inequalities in the use of secondary prevention of E-LibraryStipram
elibrary.stipram.ac.id
... ProfPhD, Daniel J Corsi, PhD, Gilles R Dagenais, MD, Antonio L Dans, MD, Rafael Diaz, MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, ...
Inequalities in the use of secondary prevention of cardiovascular ...Saudi Arabian Monetary Agency
samafind.sama.gov.sa
... ProfPhD, Daniel J Corsi, PhD, Gilles R Dagenais, MD, Antonio L Dans, MD, Rafael Diaz, MD, Ayse N Erbakan, MD, Noorhassim Ismail, MD, Romaina Iqbal, PhD, ...
Search Resultsجامعة حفر الباطن
libportal.uhb.edu.sa
Ayse N Erbakan, MD; · Noorhassim Ismail, MD; · Romaina Iqbal, PhD; · Roya Kelishadi, MD; · Rasha Khatib, PhD; · Fernando Lanas, PhD;.
The Effect of SGLT2 Inhibitors on Heart Rate Variability and ...Clinical Trials (.gov)
clinicaltrials.gov
— Goztepe Training and Research Hospital. Information provided by (Responsible Party):. Ayse N Erbakan, Goztepe Training and Research Hospital.
Inequalities in the use of secondary prevention ...X-MOL
www.x-mol.com
— ... Daniel J Corsi , Gilles R Dagenais , Antonio L Dans , Rafael Diaz , Ayse N Erbakan , Noorhassim Ismail , Romaina Iqbal , Roya Kelishadi ...
Ayse Erbakan | LinkedIn
www.linkedin.com
LinkedIn is the world's largest business network, helping professionals like Ayse Erbakan discover inside connections to recommended job candidates, industry ...
Ayse Erbakan | LinkedIn
www.linkedin.com
View Ayse Erbakan's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Ayse Erbakan discover inside ...
C-peptide Concentrations in Type 2 Diabetes Treated With Insulin; is...
clinicaltrials.gov
Ayse N Erbakan, Goztepe Training and Research Hospital. Study Details · Tabular View; No Results Posted; Disclaimer; How to Read a Study ...
Soyadı E ile başlayan kişiler (erkan) | Sayfa | İsim Arama...
www.kiminismi.com
ayse-erbakan.kiminismi.com. Ayse Erbakan kimdir, Ayse Erbakan telefon numarası, Ayse Erbakan nerede çalışıyor, Ayse Erbakan hakkında haberler ...
Soyadı E ile başlayan kişiler (erbakan) | Sayfa | İsim Arama...
www.kiminismi.com
Ayşe Erbakan · ayse-erbakan.kiminismi.com. Ayşe Erbakan hakkında bilgi, Ayşe Erbakan web adresi, Ayşe Erbakan hesap numaraları, Ayşe Erbakan hakkında döküman ...
ayşe arman zeynep erbakan hürriyet avukat
www.habername.com
Ayşe Arman, Zeynep Erbakan'la yapamadığı röportaj sonrası yaşadıklarını anlattı.
Verwandte Suchanfragen zu Ayse N. Erbakan
|
Personen Vorname "Ayse" (2618) Name "Erbakan" (19) |
sortiert nach Relevanz / Datum